GoodRx Holdings (GDRX) Total Liabilities (2019 - 2026)

GoodRx Holdings has disclosed Total Liabilities across 8 years of filings, most recently posting $1.7 billion for Q2 2026.

• In Q2 2026, Total Liabilities rose 150.91% year-over-year to $1.7 billion; the TTM figure through Jun 2026 stood at $1.7 billion (up 150.91% YoY), while the FY2025 annual figure was $787.8 million, up 18.75% from the prior year.
• Total Liabilities came in at $1.7 billion for Q2 2026 at GoodRx Holdings, up from $1.4 billion in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $1.7 billion in Q2 2026 to a low of $640.9 million in Q1 2025.
• Average Total Liabilities over 5 years is $844.6 million, with a median of $785.9 million recorded in 2023.
• Year-over-year, Total Liabilities dropped 22.11% in 2025 and surged 150.91% in 2026.
• Over 5 years, Total Liabilities stood at $789.8 million in 2022, then increased by 4.69% to $826.8 million in 2023, then slipped by 19.77% to $663.4 million in 2024, then grew by 18.75% to $787.8 million in 2025, then surged by 115.2% to $1.7 billion in 2026.
• Per Business Quant data, the three most recent Total Liabilities figures were $1.7 billion in Q2 2026, $1.4 billion in Q1 2026, and $787.8 million in Q4 2025.